Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 2.820
+0.010 (0.35%)
Apr 21, 2026, 4:08 PM HKT
Luye Pharma Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 471.89 | 532.61 | 604.81 | -134.39 |
Depreciation & Amortization | 783.39 | 693.73 | 663.46 | 577 |
Other Amortization | 7.28 | 8.12 | 7.86 | 4.99 |
Loss (Gain) From Sale of Assets | -18.49 | -1.5 | 0.21 | -11.36 |
Asset Writedown & Restructuring Costs | - | - | 11.47 | - |
Loss (Gain) From Sale of Investments | -1.79 | -1.94 | -1.55 | 14.81 |
Loss (Gain) on Equity Investments | 0.77 | -0.79 | -0.83 | -10.27 |
Stock-Based Compensation | 21.5 | 20.64 | 25.45 | 49.98 |
Other Operating Activities | 136.97 | -53.37 | 23.14 | 109.71 |
Change in Accounts Receivable | -424.88 | -570.84 | -18.77 | -211.76 |
Change in Inventory | -84.03 | -54.92 | -26.6 | -134.04 |
Change in Accounts Payable | -77.89 | 207.24 | -10.95 | 43.64 |
Change in Unearned Revenue | 9.97 | -74.87 | -42.47 | -6.43 |
Change in Other Net Operating Assets | -656.92 | 891.38 | 418.57 | -109.49 |
Operating Cash Flow | 167.76 | 1,595 | 1,654 | 182.37 |
Operating Cash Flow Growth | -89.48% | -3.53% | 806.83% | -82.35% |
Capital Expenditures | -594.07 | -632.66 | -655.68 | -556.2 |
Sale of Property, Plant & Equipment | 7.44 | 3.17 | 5.66 | 13.77 |
Divestitures | -0.02 | - | - | - |
Sale (Purchase) of Intangibles | -1,113 | -532.61 | -507.68 | -985.4 |
Investment in Securities | 536.35 | -511.14 | -675.93 | -2,057 |
Other Investing Activities | 162.36 | 254.97 | 175.32 | 148.46 |
Investing Cash Flow | -1,471 | -1,418 | -1,658 | -3,436 |
Short-Term Debt Issued | - | 4.96 | 10.1 | - |
Long-Term Debt Issued | 10,119 | 8,077 | 7,656 | 7,155 |
Total Debt Issued | 10,119 | 8,082 | 7,666 | 7,155 |
Short-Term Debt Repaid | - | -15.06 | - | - |
Long-Term Debt Repaid | -8,263 | -8,555 | -8,323 | -7,561 |
Total Debt Repaid | -8,263 | -8,570 | -8,323 | -7,561 |
Net Debt Issued (Repaid) | 1,856 | -488.07 | -656.23 | -406.32 |
Issuance of Common Stock | - | 922.97 | - | 1,044 |
Other Financing Activities | 1,101 | 406.7 | 710.38 | 1,241 |
Financing Cash Flow | 2,956 | 841.6 | 54.15 | 1,879 |
Foreign Exchange Rate Adjustments | 45.41 | -103.6 | -164.15 | -52.37 |
Net Cash Flow | 1,698 | 915.23 | -114.51 | -1,427 |
Free Cash Flow | -426.31 | 962.83 | 998.11 | -373.83 |
Free Cash Flow Growth | - | -3.54% | - | - |
Free Cash Flow Margin | -7.03% | 15.67% | 16.69% | -7.19% |
Free Cash Flow Per Share | -0.11 | 0.26 | 0.29 | -0.11 |
Cash Interest Paid | 450.1 | 471.51 | 369.2 | 297.12 |
Cash Income Tax Paid | 206.93 | 132.23 | 92.77 | 270.74 |
Levered Free Cash Flow | -2,501 | 629.06 | -43 | -778.54 |
Unlevered Free Cash Flow | -2,150 | 1,051 | 251.85 | -528.88 |
Change in Working Capital | -1,234 | 397.99 | 319.79 | -418.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.